Novo Nordisk A/S (NYSE:NVO)

46.84
Delayed Data
As of Jun 22
 +0.44 / +0.95%
Today’s Change
41.03
Today|||52-Week Range
58.37
-12.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
AssetsCash3.3B3.0B3.0B1.7B
 
 
 
 
 
Short Term Investment Cash507.0M-111.8M-261.9M-1.1B
 
 
 
 
 
Cash & Short Term Investments3.5B3.4B3.4B2.1B
 
 
 
 
 
 
ReceivablesReceivables2.8B2.8B3.8B3.1B
 
 
 
 
 
 
InventoriesInventories2.3B2.4B2.5B2.6B
 
 
 
 
 
 
Current AssetsOther Current Assets434.1M418.1M0.00438.9M
 
 
 
 
Current Assets9.0B9.1B9.7B8.2B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----10.4B--
 
 
Depreciation-----4.7B--
 
 
Intangible Assets406.0M415.4M536.3M665.7M
 
 
 
 
 
Other Assets406.0M415.4M536.3M665.7M
 
 
 
 
 
Total Assets15.0B15.6B16.5B15.4B
 
 
 
 
 
 
LiabilitiesAccounts Payable653.0M719.6M904.8M679.3M
 
 
 
 
 
Short Term Debt258.2M41.3M273.2M37.6M
 
 
 
 
 
Accrued Expenses----48.4M--
 
 
Other Current Liabilities5.2B5.5B5.7B5.9B
 
 
 
 
 
Other Liabilities6.7B7.2B7.6B7.3B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-267.7M-235.6M-176.6M-185.3M
 
 
 
 
 
Total Liabilities7.6B8.1B8.5B8.1B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity7.4B7.5B8.0B7.3B
 
 
 
 
 
Total Shareholder Equity7.4B7.5B8.0B7.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0B2.0B1.9B1.9B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.